4 completed, 1 unknown, 1 withdrawn. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Small Intestine Cancer: new trials by email Literature Review of Small Intestine Cancer trials Research Report on Small Intestine Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia amoxicillin-clavulanate potassium, ciprofloxacin, psychosocial assessment and care - Brain and Central Nervous System Tumors, Lymphoma | Phase 3 | Unknown | Clatterbridge Centre for Oncology | 400 | 2007-07-01 | 2013-08-12 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 100 | 2000-10-01 | 2016-07-06 |
| Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma levofloxacin - Brain and Central Nervous System Tumors, Breast Cancer | Phase 3 | Completed | Cancer Research Campaign Clinical Trials Centre | 1999-08-01 | 2013-08-02 | |
| Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis exisulind - Colorectal Cancer, Small Intestine Cancer | Phase 2 / Phase 3 | Withdrawn | University of Utah | 1999-07-01 | 2013-07-24 | |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy epoetin alfa, placebo - Anemia, Breast Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 344 | 1998-12-01 | 2016-07-13 |
| Treatment for Chronic Pain in Patients With Advanced Cancer dextromethorphan hydrobromide, morphine sulfate - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | NCIC Clinical Trials Group | 87 | 1998-06-11 | 2020-04-03 |
Lymphoma (5) · Burkitt Lymphoma (4) · Hodgkin Disease (4) · Immunoblastic Lymphadenopathy (4) · Leukemia, Lymphocytic, Chronic, B-Cell (4) · Lymphoma, B-Cell, Marginal Zone (4) · Lymphoma, Follicular (4) · Lymphoma, Large B-Cell, Diffuse (4) · Lymphoma, Large-Cell, Anaplastic (4) · Lymphoma, Large-Cell, Immunoblastic (4) · Lymphoma, Mantle-Cell (4) · Lymphoma, Non-Hodgkin (4) · Lymphoma, T-Cell, Cutaneous (4) · Mycosis Fungoides (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)
Neoplasms (6) · Neoplasms by Site (6) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms by Histologic Type (5) · Blood Protein Disorders (4) · Cardiovascular Diseases (4) · Chronic Disease (4) · DNA Virus Infections (4) · Disease Attributes (4) · Epstein-Barr Virus Infections (4)
Amoxicillin-Potassium Clavulanate Combination (1) · Ciprofloxacin (1) · Dextromethorphan (1) · Epoetin Alfa (1) · Levofloxacin (1) · Morphine (1) · Ondansetron (1) · Psychiatric Rehabilitation (1) · sulindac sulfone (1)
Alliance for Clinical Trials in Oncology (2) · Cancer Research Campaign Clinical Trials Centre (1) · Clatterbridge Centre for Oncology (1) · NCIC Clinical Trials Group (1) · University of Utah (1)
Canada (2) · United Kingdom (2) · United States (2)
Eduardo Bruera, MD (1) · Ernest Marshall, MD (1) · James A. DiSario, MD (1) · Steven M. Neil, MB, MA, BS, PhD, DTMH, MRCP (1) · Steven R. Alberts, MD (1) · Thomas E. Witzig, MD (1)
P30CA042014 (1), R01CA080852 (1)